Literature DB >> 1151137

Urinary iron in patients with sickle cell anamia.

R Washington, D R Boggs.   

Abstract

Urinary iron excretion was measured in patients with sickle cell anemia and relateddiseases. Iron concentration in urine was determined by atomic absorption spectrophotometry and daily total iron excretion was calculated from this and total daily urine volume. Normal subjects excreted a mean of 88 pg Fe per day (95 per cent confidence limitsof 0 to 120 pg). Nine persons with sickle cell trait had normal Fe excretion rates.However, abnormally high iron excretion was present in the first urine sample obtainedfrom 27/31 patients with SS, 3/7 with SC, 1/2 with CC, and 1 with S-thalassemia. Iron excretion varied very significantly from day-to-day in individual patients. The results of studies attemting to relate this to increase excretion during activityas compared to rest were negative. No clear relationship of iron excretion to painfulcrisis could be shown, but remarkable rises in urine iron occurred in two patients who developed a hyperhemolytic crisis. These studies suggest that urinary iron reflects intravascular hemolysis primarily. No correlation was evident between urine iron and the patients' age, transfusion history, or serum iron values suggesting increased urinary iron excretion cannot be attributed to iron overload in sickle cell anemia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1151137

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  3 in total

Review 1.  Nutritional support in sickle cell anemia: theoretical considerations.

Authors:  C O Enwonwu
Journal:  J Natl Med Assoc       Date:  1988-02       Impact factor: 1.798

2.  Iron deficiency in sickle cell anaemia.

Authors:  S Davies; J Henthorn; M Brozović
Journal:  J Clin Pathol       Date:  1983-09       Impact factor: 3.411

3.  Impact of aging on urinary excretion of iron and zinc.

Authors:  Karina Pfrimer; Rutinéia Fátima Micheletto; Julio Sergio Marchini; Gilberto João Padovan; Julio Cesar Moriguti; Eduardo Ferriolli
Journal:  Nutr Metab Insights       Date:  2014-05-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.